Skip to main content
SpringerLink
Log in

Risk of osteoporotic fracture lower with DOACs than warfarin

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lau WCY, et al. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation. A Population-Based Cohort Study. Annals of Internal Medicine : 19 May 2020. Available from: URL: https://doi.org/10.7326/M19-3671

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of osteoporotic fracture lower with DOACs than warfarin. Reactions Weekly 1806, 14 (2020). https://doi.org/10.1007/s40278-020-79032-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-79032-8

Search

Navigation